Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 2.0 | 1.1 | 0.5 | 0.0 | 0.0 |
| Revenue growth | | | -100.0% | 87.8% | 132.3% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | -21.4 | -24.7 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 23.5 | 25.8 | 0.5 | 0.0 | 0.0 |
| Gross margin | | | | 1151.5% | 2379.1% | 100.0% | | |
| Research and development | 27.2 | 26.1 | 18.2 | 8.3 | 9.7 | 14.3 | 7.6 | 6.7 |
| General and administrative | 5.7 | 4.1 | 4.2 | 4.4 | 3.8 | 3.1 | 3.2 | 2.5 |
| EBIT | -32.1 | -27.3 | -18.5 | 10.7 | 12.4 | 16.9 | 10.4 | 9.1 |
| EBIT margin | | | | 525.8% | 1139.5% | 3615.0% | | |
| Pre-tax income | -32.5 | -28.8 | -20.5 | 9.8 | 12.3 | 16.8 | 10.6 | 9.1 |
| Income taxes | -64.9 | -57.5 | -40.9 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 |
| Tax rate | 200.0% | 200.0% | 200.0% | | 0.0% | | 0.0% | 0.0% |
| Net income | 32.5 | 28.8 | 20.5 | 9.9 | 12.3 | 17.0 | 10.6 | 9.1 |
| Net margin | | | | 483.6% | 1133.5% | 3630.2% | | |
| |
| Diluted EPS | $1.32 | $1.35 | $0.97 | $0.54 | $0.98 | $1.49 | $0.96 | $0.88 |
| Shares outstanding (diluted) | 24.6 | 21.3 | 21.1 | 18.1 | 12.5 | 11.4 | 11.1 | 10.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|